EligibleTrials

Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer

Recruiting · NCT04678583 · Interventional (participants receive a specific treatment)

View the official record on ClinicalTrials.gov →
Colorectal cancer

Interventions studied

Resection of colorectal liver metastases

What this trial is about

the ARMANI trial will test the hypothesis, if an anatomic resection (AR) improves long-term outcome vs. a non-anatomical resection (NAR) in patients undergoing surgery for RAS-mutated colorectal liver metastasis (CRLM).

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

37 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.